Innodem Neurosciences

Montreal, Canada Founded: 2016 • Age: 10 yrs
AI-based eye movement tracking is used for patient communication.

About Innodem Neurosciences

Innodem Neurosciences is a company based in Montreal (Canada) founded in 2016.. Innodem Neurosciences has raised $7 million across 2 funding rounds from investors including Morningside. Innodem Neurosciences offers products and services including ETNA™-MS and Pigio™. Innodem Neurosciences operates in a competitive market with competitors including Kernel, MapHabit, Rhaeos, Cognetivity and HitCheck, among others.

  • Headquarter Montreal, Canada
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $7 M (USD)

    in 2 rounds

  • Latest Funding Round
    $6 M (USD), Series A

    Jan 19, 2021

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Innodem Neurosciences

Innodem Neurosciences offers a comprehensive portfolio of products and services, including ETNA™-MS and Pigio™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Eye-tracking tool for assessing multiple sclerosis progression

Platform for monitoring neurological disorders via gaze analysis

People of Innodem Neurosciences
Headcount 1-10
Employee Profiles 7
Employee Profiles
People
Francis Arseneau
Vice President Operations
People
Martin Poirier-Theoret
Software Architect
People
Nils Koch
Research Intern

Unlock access to complete

Funding Insights of Innodem Neurosciences

Innodem Neurosciences has successfully raised a total of $7M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $6.0M
  • First Round

    (19 Feb 2019)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2021 Amount Series A - Innodem Neurosciences Valuation Morningside
Feb, 2019 Amount Seed - Innodem Neurosciences Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Innodem Neurosciences

Innodem Neurosciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Morningside. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Multiple sectors are invested in by Morningside, a VC fund.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Innodem Neurosciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Innodem Neurosciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Innodem Neurosciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Innodem Neurosciences

Innodem Neurosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kernel, MapHabit, Rhaeos, Cognetivity and HitCheck, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multimodal brain measurement technology is developed for neuromedicine applications.
domain founded_year HQ Location
Wearable devices and app are provided for mental disorder support.
domain founded_year HQ Location
Noninvasive device developed for CSF monitoring and hydrocephalus management.
domain founded_year HQ Location
AI based platform offering brain health diagnosis tool for providers
domain founded_year HQ Location
A mobile app that helps to screen for signs of a concussion
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Innodem Neurosciences

When was Innodem Neurosciences founded?

Innodem Neurosciences was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Where is Innodem Neurosciences located?

Innodem Neurosciences is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.

Is Innodem Neurosciences a funded company?

Innodem Neurosciences is a funded company, having raised a total of $7M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Feb 19, 2019.

What does Innodem Neurosciences do?

Innodem Neurosciences was founded in 2016 in Montreal, Canada, within the healthcare and AI sector. A software platform named Pigio is offered to support communication for patients with neurological impairments. Eye movements of paralyzed or mentally ill individuals are predicted and monitored through dashboard tools, facilitating interaction. Treatment processes are refined by physicians and healthcare providers using the AI-driven features.

Who are the top competitors of Innodem Neurosciences?

Innodem Neurosciences's top competitors include Kernel, Winterlight Labs and Cognetivity.

What products or services does Innodem Neurosciences offer?

Innodem Neurosciences offers ETNA™-MS and Pigio™.

Who are Innodem Neurosciences's investors?

Innodem Neurosciences has 1 investor. Key investors include Morningside.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available